Research Site

Strasbourg, Alsace 67000

1 studies enrolling now · 2 studies all time

What they study most

Hepatobiliary Cancers, Relapsing-Remitting Multiple Sclerosis

Studies at this site

• Observational Study Protocol: LIVER-R — Recruiting now
• Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis — Completed